德创系列整机产品

Search documents
科德数控(688305):航空航天优势巩固,民用领域拓展优势显著
Changjiang Securities· 2025-08-27 13:54
Investment Rating - The investment rating for the company is "Buy" and is maintained [9] Core Viewpoints - The company reported a revenue increase of 15.24% year-on-year for H1 2025, with a net profit increase of 1.27% year-on-year, while the net profit excluding non-recurring items decreased by 7.43% [6][9] - The company is one of the few domestic machine tool manufacturers with a complete industrial chain, and it is actively expanding its production capacity and integrated layout, which is expected to open up growth opportunities [9] - The company has strengthened its advantages in the aerospace sector while significantly expanding its presence in the civilian market, responding to the increasing demand for five-axis CNC machine tools [11][12] Summary by Sections Financial Performance - In H1 2025, the company's revenue was up 15.24% year-on-year, while net profit increased by 1.27%. However, the net profit excluding non-recurring items fell by 7.43% [6][9] - The gross margin for H1 2025 improved by 2.15 percentage points compared to 2024, despite a higher proportion of revenue coming from lower-margin production lines [2][11] Market Expansion - The company has successfully opened new users in the aerospace sector and has established a joint venture to create a testing base for high-end five-axis CNC machine tools [11] - The demand for five-axis CNC machine tools in the civilian sector has surged, with new orders for the company's high-performance products significantly increasing [11][12] Product Development - The company has seen high recognition for its new products, with over 50% of new orders coming from flow-type products and significant interest in its new series of five-axis machining centers [11] - The introduction of the DMC55 series has been well-received by private clients, contributing to the growth in new orders [11] Capacity Expansion - The company is progressing with its capacity expansion projects, with new production lines expected to start trial operations in 2025 [11][12] - The implementation of fundraising projects is anticipated to optimize capacity layout and increase market share for leading products [11]